| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent activity | KIF23 VWA8 MYO7B ABCA13 ACSM1 WRN RFC5 DNAH7 DDX3X ABCA6 ASCC3 DHX34 ATP4A DYNC1H1 KIF11 | 2.33e-05 | 614 | 138 | 15 | GO:0140657 |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | CDK8 PDGFRA CDK19 CSK PIK3C2G GUCY2C CLK1 CLK2 CLK3 BTK CHEK2 TAF1 TAF1L TSSK4 G6PC1 PLK4 | 3.21e-05 | 709 | 138 | 16 | GO:0016773 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | KIF23 VWA8 ABCA13 WRN RFC5 DNAH7 DDX3X ABCA6 ASCC3 DHX34 ATP4A DYNC1H1 | 5.74e-05 | 441 | 138 | 12 | GO:0016887 |
| GeneOntologyMolecularFunction | protein kinase activity | CDK8 PDGFRA CDK19 CSK GUCY2C CLK1 CLK2 CLK3 BTK CHEK2 TAF1 TAF1L TSSK4 PLK4 | 7.23e-05 | 600 | 138 | 14 | GO:0004672 |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | CDK8 PDGFRA CDK19 PARP1 POLR3B CSK PIK3C2G GUCY2C CLK1 CLK2 CLK3 BTK CHEK2 TAF1 TAF1L TSSK4 G6PC1 PLK4 | 8.33e-05 | 938 | 138 | 18 | GO:0016772 |
| GeneOntologyMolecularFunction | kinase activity | CDK8 PDGFRA CDK19 CSK PIK3C2G GUCY2C CLK1 CLK2 CLK3 BTK CHEK2 TAF1 TAF1L TSSK4 PLK4 | 2.65e-04 | 764 | 138 | 15 | GO:0016301 |
| GeneOntologyMolecularFunction | H3K27me3 modified histone binding | 4.68e-04 | 5 | 138 | 2 | GO:0061628 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on ester bonds | PDE3B ABHD12B PLCXD2 WRN PIWIL4 PNLDC1 PP2D1 ANKZF1 LPIN2 XRN1 PLCD1 G6PC1 LRRD1 DNASE1L1 SMG6 | 4.72e-04 | 807 | 138 | 15 | GO:0016788 |
| GeneOntologyMolecularFunction | protein tyrosine kinase activity | 5.18e-04 | 145 | 138 | 6 | GO:0004713 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | WRN PIWIL4 PNLDC1 RFC5 ANKZF1 TRMT2B DDX3X POLR3B XRN1 ASCC3 DHX34 DNASE1L1 SMG6 | 5.41e-04 | 645 | 138 | 13 | GO:0140640 |
| GeneOntologyMolecularFunction | protein kinase A binding | 6.94e-04 | 58 | 138 | 4 | GO:0051018 | |
| GeneOntologyMolecularFunction | histone H3K4me/H3K4me2/H3K4me3 demethylase activity | 6.98e-04 | 6 | 138 | 2 | GO:0034647 | |
| GeneOntologyMolecularFunction | metalloaminopeptidase activity | 7.47e-04 | 26 | 138 | 3 | GO:0070006 | |
| GeneOntologyMolecularFunction | DNA helicase activity | 8.93e-04 | 62 | 138 | 4 | GO:0003678 | |
| GeneOntologyMolecularFunction | protein serine kinase activity | 9.63e-04 | 363 | 138 | 9 | GO:0106310 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | 1.09e-03 | 446 | 138 | 10 | GO:0004674 | |
| GeneOntologyMolecularFunction | nuclease activity | 1.14e-03 | 231 | 138 | 7 | GO:0004518 | |
| GeneOntologyMolecularFunction | histone H3K4 demethylase activity | 1.29e-03 | 8 | 138 | 2 | GO:0032453 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 1.37e-03 | 118 | 138 | 5 | GO:0003774 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 1.41e-03 | 70 | 138 | 4 | GO:0003777 | |
| GeneOntologyMolecularFunction | RNA polymerase I general transcription initiation factor activity | 1.65e-03 | 9 | 138 | 2 | GO:0001181 | |
| GeneOntologyMolecularFunction | 7SK snRNA binding | 1.65e-03 | 9 | 138 | 2 | GO:0097322 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activator activity | 2.10e-03 | 78 | 138 | 4 | GO:0043539 | |
| GeneOntologyCellularComponent | nuclear cyclin-dependent protein kinase holoenzyme complex | 5.03e-06 | 18 | 137 | 4 | GO:0019908 | |
| GeneOntologyCellularComponent | chromosome, telomeric region | 2.14e-05 | 176 | 137 | 8 | GO:0000781 | |
| GeneOntologyCellularComponent | CKM complex | 4.21e-04 | 5 | 137 | 2 | GO:1990508 | |
| GeneOntologyCellularComponent | chromosomal region | 4.67e-04 | 421 | 137 | 10 | GO:0098687 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | CDK8 OGT CTC1 CDK19 U2AF1L4 RFC5 THOC2 MED15 CCNT1 ORC5 CCNT2 ARNT POLR3B TAF1 ASCC3 TAF1L NR1H4 SMG6 SYMPK XPO7 | 6.54e-04 | 1377 | 137 | 20 | GO:0140513 |
| GeneOntologyCellularComponent | microtubule associated complex | 6.81e-04 | 161 | 137 | 6 | GO:0005875 | |
| GeneOntologyCellularComponent | cyclin-dependent protein kinase holoenzyme complex | 6.90e-04 | 61 | 137 | 4 | GO:0000307 | |
| GeneOntologyCellularComponent | pronucleus | 8.00e-04 | 28 | 137 | 3 | GO:0045120 | |
| GeneOntologyCellularComponent | pole plasm | 8.88e-04 | 29 | 137 | 3 | GO:0045495 | |
| GeneOntologyCellularComponent | germ plasm | 8.88e-04 | 29 | 137 | 3 | GO:0060293 | |
| GeneOntologyCellularComponent | P granule | 8.88e-04 | 29 | 137 | 3 | GO:0043186 | |
| GeneOntologyCellularComponent | centriole | 9.61e-04 | 172 | 137 | 6 | GO:0005814 | |
| GeneOntologyCellularComponent | microtubule organizing center | KIF23 UBR4 WRN DDX3X CEP55 ACTR1B ACTR1A RESF1 AKAP9 CEP295 HERC2 CEP57 PLK4 DYNC1H1 PCNT | 1.03e-03 | 919 | 137 | 15 | GO:0005815 |
| GeneOntologyCellularComponent | dynactin complex | 1.16e-03 | 8 | 137 | 2 | GO:0005869 | |
| GeneOntologyCellularComponent | cyclin/CDK positive transcription elongation factor complex | 1.49e-03 | 9 | 137 | 2 | GO:0008024 | |
| GeneOntologyCellularComponent | centrosome | KIF23 UBR4 WRN DDX3X CEP55 ACTR1B ACTR1A AKAP9 CEP295 CEP57 PLK4 DYNC1H1 PCNT | 1.67e-03 | 770 | 137 | 13 | GO:0005813 |
| GeneOntologyCellularComponent | transferase complex, transferring phosphorus-containing groups | 1.67e-03 | 335 | 137 | 8 | GO:0061695 | |
| GeneOntologyCellularComponent | nuclear speck | 2.18e-03 | 431 | 137 | 9 | GO:0016607 | |
| GeneOntologyCellularComponent | nuclear body | WRN U2AF1L4 APBB1 THOC2 ERBIN PALB2 PARP1 ARNT CLK2 CLK3 CHEK2 CBX1 ASCC3 SYMPK | 2.45e-03 | 903 | 137 | 14 | GO:0016604 |
| MousePheno | abnormal mitosis | 6.72e-07 | 128 | 109 | 9 | MP:0004046 | |
| Domain | ARM-type_fold | PDS5B NBEAL1 UBR4 HUWE1 IPO9 PIK3C2G AOPEP DIAPH2 GCN1 TANGO6 SYMPK XPO7 | 7.13e-06 | 339 | 136 | 12 | IPR016024 |
| Domain | TFIID_sub1_DUF3591 | 5.26e-05 | 2 | 136 | 2 | IPR022591 | |
| Domain | PACT_coil_coil | 5.26e-05 | 2 | 136 | 2 | PF10495 | |
| Domain | TBP-binding | 5.26e-05 | 2 | 136 | 2 | PF09247 | |
| Domain | DUF3591 | 5.26e-05 | 2 | 136 | 2 | PF12157 | |
| Domain | Arp1 | 5.26e-05 | 2 | 136 | 2 | IPR029909 | |
| Domain | TAF_II_230-bd | 5.26e-05 | 2 | 136 | 2 | IPR009067 | |
| Domain | - | 5.26e-05 | 2 | 136 | 2 | 1.10.1100.10 | |
| Domain | PACT_domain | 5.26e-05 | 2 | 136 | 2 | IPR019528 | |
| Domain | TAF1_animal | 5.26e-05 | 2 | 136 | 2 | IPR011177 | |
| Domain | AAA | 8.92e-05 | 144 | 136 | 7 | SM00382 | |
| Domain | AAA+_ATPase | 8.92e-05 | 144 | 136 | 7 | IPR003593 | |
| Domain | Kinase-like_dom | CDK8 PDGFRA CDK19 CSK PIK3C2G GUCY2C CLK1 CLK2 CLK3 BTK CHEK2 TSSK4 PLK4 | 1.67e-04 | 542 | 136 | 13 | IPR011009 |
| Domain | Prot_kinase_dom | CDK8 PDGFRA CDK19 CSK GUCY2C CLK1 CLK2 CLK3 BTK CHEK2 TSSK4 PLK4 | 2.44e-04 | 489 | 136 | 12 | IPR000719 |
| Domain | PROTEIN_KINASE_DOM | CDK8 PDGFRA CDK19 CSK GUCY2C CLK1 CLK2 CLK3 BTK CHEK2 TSSK4 PLK4 | 2.63e-04 | 493 | 136 | 12 | PS50011 |
| Domain | Lys_sp_deMease-like_dom | 3.13e-04 | 4 | 136 | 2 | IPR013637 | |
| Domain | PLU-1 | 3.13e-04 | 4 | 136 | 2 | PF08429 | |
| Domain | Protein_kinase_ATP_BS | 4.64e-04 | 379 | 136 | 10 | IPR017441 | |
| Domain | zf-C5HC2 | 5.19e-04 | 5 | 136 | 2 | PF02928 | |
| Domain | Znf_C5HC2 | 5.19e-04 | 5 | 136 | 2 | IPR004198 | |
| Domain | PROTEIN_KINASE_ATP | 5.42e-04 | 459 | 136 | 11 | PS00107 | |
| Domain | S_TKc | 1.28e-03 | 359 | 136 | 9 | SM00220 | |
| Domain | P-loop_NTPase | KIF23 VWA8 MYO7B ABCA13 WRN RFC5 DNAH7 DDX3X ORC5 SAMD9L ABCA6 ASCC3 DHX34 DYNC1H1 KIF11 | 1.32e-03 | 848 | 136 | 15 | IPR027417 |
| Domain | Cyclin_L/T | 1.43e-03 | 8 | 136 | 2 | IPR015429 | |
| Domain | Pkinase | 1.92e-03 | 381 | 136 | 9 | PF00069 | |
| Domain | DEAD/DEAH_box_helicase_dom | 1.98e-03 | 73 | 136 | 4 | IPR011545 | |
| Domain | DEAD | 1.98e-03 | 73 | 136 | 4 | PF00270 | |
| Domain | JmjN | 2.28e-03 | 10 | 136 | 2 | SM00545 | |
| Domain | JmjN | 2.28e-03 | 10 | 136 | 2 | PF02375 | |
| Domain | JMJN | 2.28e-03 | 10 | 136 | 2 | PS51183 | |
| Domain | JmjN | 2.28e-03 | 10 | 136 | 2 | IPR003349 | |
| Domain | Pkinase_Tyr | 2.54e-03 | 129 | 136 | 5 | PF07714 | |
| Domain | - | VWA8 MYO7B ABCA13 WRN RFC5 DNAH7 DDX3X ORC5 SAMD9L ABCA6 ASCC3 DHX34 DYNC1H1 | 3.15e-03 | 746 | 136 | 13 | 3.40.50.300 |
| Domain | ABC_A | 3.31e-03 | 12 | 136 | 2 | IPR026082 | |
| Domain | Peptidase_M1 | 3.31e-03 | 12 | 136 | 2 | IPR001930 | |
| Domain | Ser-Thr/Tyr_kinase_cat_dom | 3.40e-03 | 138 | 136 | 5 | IPR001245 | |
| Domain | ARM-like | 3.66e-03 | 270 | 136 | 7 | IPR011989 | |
| Domain | Peptidase_M1_N | 3.90e-03 | 13 | 136 | 2 | IPR014782 | |
| Domain | Peptidase_M1 | 3.90e-03 | 13 | 136 | 2 | PF01433 | |
| Domain | Dynein_heavy_chain_D4_dom | 4.52e-03 | 14 | 136 | 2 | IPR024317 | |
| Domain | Dynein_HC_stalk | 4.52e-03 | 14 | 136 | 2 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 4.52e-03 | 14 | 136 | 2 | IPR013602 | |
| Domain | DHC_N2 | 4.52e-03 | 14 | 136 | 2 | PF08393 | |
| Domain | IMPORTIN_B_NT | 4.52e-03 | 14 | 136 | 2 | PS50166 | |
| Domain | ATPase_dyneun-rel_AAA | 4.52e-03 | 14 | 136 | 2 | IPR011704 | |
| Domain | MT | 4.52e-03 | 14 | 136 | 2 | PF12777 | |
| Domain | AAA_8 | 4.52e-03 | 14 | 136 | 2 | PF12780 | |
| Domain | AAA_5 | 4.52e-03 | 14 | 136 | 2 | PF07728 | |
| Domain | - | 4.85e-03 | 47 | 136 | 3 | 3.30.420.10 | |
| Domain | PROTEIN_KINASE_ST | 5.07e-03 | 362 | 136 | 8 | PS00108 | |
| Domain | DHC_fam | 5.19e-03 | 15 | 136 | 2 | IPR026983 | |
| Domain | - | 5.19e-03 | 15 | 136 | 2 | 1.10.150.60 | |
| Domain | BRIGHT | 5.19e-03 | 15 | 136 | 2 | SM00501 | |
| Domain | ARID_dom | 5.19e-03 | 15 | 136 | 2 | IPR001606 | |
| Domain | ARID | 5.19e-03 | 15 | 136 | 2 | PS51011 | |
| Domain | Dynein_heavy | 5.19e-03 | 15 | 136 | 2 | PF03028 | |
| Domain | IBN_N | 5.19e-03 | 15 | 136 | 2 | PF03810 | |
| Domain | ARID | 5.19e-03 | 15 | 136 | 2 | PF01388 | |
| Domain | Dynein_heavy_dom | 5.19e-03 | 15 | 136 | 2 | IPR004273 | |
| Domain | PROTEIN_KINASE_TYR | 5.53e-03 | 97 | 136 | 4 | PS00109 | |
| Domain | Tyr_kinase_AS | 5.53e-03 | 97 | 136 | 4 | IPR008266 | |
| Domain | ZINC_PROTEASE | 5.73e-03 | 98 | 136 | 4 | PS00142 | |
| Domain | IBN_N | 5.91e-03 | 16 | 136 | 2 | SM00913 | |
| Domain | Actin_CS | 5.91e-03 | 16 | 136 | 2 | IPR004001 | |
| Domain | Importin-beta_N | 6.66e-03 | 17 | 136 | 2 | IPR001494 | |
| Domain | ACTINS_2 | 6.66e-03 | 17 | 136 | 2 | PS00432 | |
| Pathway | REACTOME_ANCHORING_OF_THE_BASAL_BODY_TO_THE_PLASMA_MEMBRANE | 4.55e-06 | 97 | 97 | 7 | M27478 | |
| Pathway | REACTOME_AURKA_ACTIVATION_BY_TPX2 | 9.84e-06 | 72 | 97 | 6 | M27749 | |
| Pathway | REACTOME_CELL_CYCLE | PDS5B KIF23 CTC1 WRN RFC5 SPC24 ACTR1A ORC5 AKAP9 LPIN2 CHEK2 HERC2 CEP57 PLK4 DYNC1H1 | 1.48e-05 | 603 | 97 | 15 | MM14635 |
| Pathway | REACTOME_CELL_CYCLE | PDS5B KIF23 CTC1 WRN RFC5 SPC24 ACTR1A ORC5 AKAP9 LPIN2 CHEK2 HERC2 CEP57 PLK4 DYNC1H1 PCNT | 1.90e-05 | 694 | 97 | 16 | M543 |
| Pathway | WP_DNA_IRDAMAGE_AND_CELLULAR_RESPONSE_VIA_ATR | 1.94e-05 | 81 | 97 | 6 | M39490 | |
| Pathway | REACTOME_RECRUITMENT_OF_MITOTIC_CENTROSOME_PROTEINS_AND_COMPLEXES | 1.94e-05 | 81 | 97 | 6 | M748 | |
| Pathway | REACTOME_REGULATION_OF_PLK1_ACTIVITY_AT_G2_M_TRANSITION | 2.93e-05 | 87 | 97 | 6 | M27194 | |
| Pathway | REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES | 4.82e-05 | 95 | 97 | 6 | M6729 | |
| Pathway | REACTOME_ANCHORING_OF_THE_BASAL_BODY_TO_THE_PLASMA_MEMBRANE | 5.11e-05 | 96 | 97 | 6 | MM15207 | |
| Pathway | REACTOME_DNA_DOUBLE_STRAND_BREAK_REPAIR | 6.53e-05 | 146 | 97 | 7 | MM15292 | |
| Pathway | REACTOME_MITOTIC_PROMETAPHASE | 8.05e-05 | 204 | 97 | 8 | M4217 | |
| Pathway | REACTOME_AURKA_ACTIVATION_BY_TPX2 | 1.26e-04 | 71 | 97 | 5 | MM15495 | |
| Pathway | REACTOME_DNA_DOUBLE_STRAND_BREAK_REPAIR | 1.69e-04 | 170 | 97 | 7 | M27582 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER | 1.75e-04 | 41 | 97 | 4 | MM14876 | |
| Pathway | REACTOME_REGULATION_OF_PLK1_ACTIVITY_AT_G2_M_TRANSITION | 2.95e-04 | 85 | 97 | 5 | MM14906 | |
| Pathway | REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES | 3.85e-04 | 90 | 97 | 5 | MM14979 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER | 4.11e-04 | 51 | 97 | 4 | M665 | |
| Pathway | REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION | 4.26e-04 | 92 | 97 | 5 | MM15338 | |
| Pathway | REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION | 4.26e-04 | 92 | 97 | 5 | M27636 | |
| Pathway | REACTOME_CELL_CYCLE_MITOTIC | PDS5B KIF23 RFC5 SPC24 ACTR1A ORC5 AKAP9 LPIN2 CEP57 PLK4 DYNC1H1 PCNT | 4.57e-04 | 561 | 97 | 12 | M5336 |
| Pathway | REACTOME_CILIUM_ASSEMBLY | 4.69e-04 | 201 | 97 | 7 | M27472 | |
| Pathway | REACTOME_MITOTIC_PROMETAPHASE | 4.83e-04 | 202 | 97 | 7 | MM15362 | |
| Pathway | REACTOME_GENE_EXPRESSION_TRANSCRIPTION | CDK8 OGT WRN U2AF1L4 RFC5 THOC2 CCNT1 CCNT2 PARP1 ZNF836 ARNT POLR3B CHEK2 TAF1 TAF1L NR1H4 SYMPK | 5.55e-04 | 1022 | 97 | 17 | MM15436 |
| Pathway | REACTOME_M_PHASE | PDS5B KIF23 SPC24 ACTR1A AKAP9 LPIN2 CEP57 PLK4 DYNC1H1 PCNT | 5.84e-04 | 417 | 97 | 10 | M27662 |
| Pathway | REACTOME_SMAD2_SMAD3_SMAD4_HETEROTRIMER_REGULATES_TRANSCRIPTION | 7.32e-04 | 26 | 97 | 3 | MM14878 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_RETROGRADE_AXONAL_TRANSPORT | 8.19e-04 | 27 | 97 | 3 | M47755 | |
| Pathway | REACTOME_HOMOLOGY_DIRECTED_REPAIR | 1.22e-03 | 116 | 97 | 5 | MM15294 | |
| Pathway | REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION | 1.22e-03 | 116 | 97 | 5 | MM14855 | |
| Pathway | REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA | 1.32e-03 | 118 | 97 | 5 | M27316 | |
| Pathway | REACTOME_SIGNALING_BY_TGFB_FAMILY_MEMBERS | 1.32e-03 | 118 | 97 | 5 | MM15588 | |
| Pathway | REACTOME_TRANSCRIPTION_OF_THE_HIV_GENOME | 1.36e-03 | 70 | 97 | 4 | M27008 | |
| Pathway | REACTOME_M_PHASE | 1.37e-03 | 387 | 97 | 9 | MM15364 | |
| Pubmed | CDK8 KIF23 OGT MATN2 U2AF1L4 HUWE1 RFC5 THOC2 ERBIN DDX3X MED15 CCNT1 ACTR1A CCNT2 PARP1 ARNT IPO9 AKAP9 XRN1 ASCC3 GCN1 DYNC1H1 | 5.22e-09 | 1247 | 139 | 22 | 27684187 | |
| Pubmed | 8.14e-09 | 146 | 139 | 9 | 21399614 | ||
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | KIF23 KDM5C UBR4 HUWE1 RFC5 DDX3X PARP1 TAF1 GCN1 DYNC1H1 KIF11 SYMPK | 1.06e-08 | 332 | 139 | 12 | 32786267 |
| Pubmed | OGT UBR4 HUWE1 PALB2 RESF1 XRN1 TAF1 CRYBG3 ASCC3 GCN1 KIF11 TANGO6 PCNT | 1.50e-08 | 418 | 139 | 13 | 34709266 | |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | KIF23 ABCA13 UBR4 DDX3X SAMD9L SERPINI2 CLK1 CHEK2 ADAMTS18 CPLANE1 ATP4A KIF11 | 2.67e-08 | 361 | 139 | 12 | 26167880 |
| Pubmed | PDE3B PDGFRA UBR4 HUWE1 ANKZF1 CEP55 MED15 ACTR1B PARP1 IPO9 CLK3 XRN1 HERC2 ASCC3 DHX34 IL2RG GCN1 DYNC1H1 KIF11 PCNT | 4.55e-08 | 1168 | 139 | 20 | 19946888 | |
| Pubmed | KIF23 OGT APBB1 HUWE1 THOC2 ERBIN CEP55 MED15 XRN1 TAF1 ASCC3 GCN1 DYNC1H1 SYMPK | 4.88e-08 | 549 | 139 | 14 | 38280479 | |
| Pubmed | 6.25e-08 | 3 | 139 | 3 | 20186884 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | PDE3B KIF23 PDGFRA PSD3 APBB1 ERBIN DNAH7 DDX3X MADD IPO9 RESF1 AKAP9 CLK3 XRN1 CRYBG3 PLK4 KIF11 | 6.88e-08 | 861 | 139 | 17 | 36931259 |
| Pubmed | The centrosomal protein C-Nap1 is required for cell cycle-regulated centrosome cohesion. | 1.01e-07 | 56 | 139 | 6 | 11076968 | |
| Pubmed | The PITSLRE/CDK11p58 protein kinase promotes centrosome maturation and bipolar spindle formation. | 1.12e-07 | 57 | 139 | 6 | 16462731 | |
| Pubmed | Polo-like kinase 1 regulates Nlp, a centrosome protein involved in microtubule nucleation. | 1.25e-07 | 58 | 139 | 6 | 12852856 | |
| Pubmed | Oct4 links multiple epigenetic pathways to the pluripotency network. | 1.40e-07 | 203 | 139 | 9 | 22083510 | |
| Pubmed | 1.69e-07 | 61 | 139 | 6 | 7790358 | ||
| Pubmed | CTNNAL1 PSD3 HUWE1 FAM171B ERBIN MADD CEP55 PARP1 IPO9 AKAP9 CSK SLC39A6 CRYBG3 HERC2 GCN1 PLK4 PCNT SYMPK | 2.21e-07 | 1049 | 139 | 18 | 27880917 | |
| Pubmed | 2.49e-07 | 4 | 139 | 3 | 7990150 | ||
| Pubmed | Chromosomal mapping of three human LAMMER protein-kinase-encoding genes. | 2.49e-07 | 4 | 139 | 3 | 9856501 | |
| Pubmed | Characterization and comparison of four serine- and arginine-rich (SR) protein kinases. | 2.49e-07 | 4 | 139 | 3 | 9307018 | |
| Pubmed | 2.73e-07 | 66 | 139 | 6 | 12221128 | ||
| Pubmed | CDK8 KIF23 HUWE1 THOC2 ERBIN PALB2 CEP55 MED15 SPC24 ACTR1A IPO9 XRN1 KIF11 PCNT | 3.45e-07 | 645 | 139 | 14 | 25281560 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | PDS5B KIF23 UBR4 HUWE1 RFC5 ERBIN ACTR1B CCNT1 ACTR1A PARP1 POLR3B IPO9 XRN1 CBX1 HERC2 ASCC3 DHX34 GCN1 DYNC1H1 KIF11 | 4.75e-07 | 1353 | 139 | 20 | 29467282 |
| Pubmed | Human mediator subunit MED26 functions as a docking site for transcription elongation factors. | 4.99e-07 | 73 | 139 | 6 | 21729782 | |
| Pubmed | RFC5 ERBIN CCNT1 CCNT2 PARP1 POLR3B IPO9 TAF1 TAF1L GCN1 KIF11 | 5.31e-07 | 390 | 139 | 11 | 17643375 | |
| Pubmed | CDK8 OGT VWA8 KDM5C RFC5 WDR37 CCNT1 RESF1 XRN1 CBX1 CEP295 TAF1 CRYBG3 ASCC3 DHX34 TSSK4 UNC80 TCTN2 | 5.43e-07 | 1116 | 139 | 18 | 31753913 | |
| Pubmed | 6.21e-07 | 5 | 139 | 3 | 19168442 | ||
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | HUWE1 RFC5 LENG9 ACTR1A ORC5 PARP1 IPO9 CSK GCN1 DYNC1H1 KIF11 PCNT SYMPK | 6.73e-07 | 582 | 139 | 13 | 20467437 |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | PDS5B KIF23 OGT ANPEP CTC1 CEP55 SPC24 ACTR1B ACTR1A ORC5 CSK CHEK2 CBX1 ZNF552 HERC2 GCN1 PLK4 DYNC1H1 | 8.88e-07 | 1155 | 139 | 18 | 20360068 |
| Pubmed | 1.24e-06 | 6 | 139 | 3 | 16198290 | ||
| Pubmed | Characterization of the interactome of the human MutL homologues MLH1, PMS1, and PMS2. | 1.42e-06 | 87 | 139 | 6 | 17148452 | |
| Pubmed | 1.62e-06 | 272 | 139 | 9 | 31010829 | ||
| Pubmed | KIF23 OGT UBR4 HUWE1 ERBIN DDX3X ACTR1A PARP1 AKAP9 SPHKAP DIAPH2 HERC2 DYNC1H1 KIF11 PCNT SMG6 | 1.66e-06 | 963 | 139 | 16 | 28671696 | |
| Pubmed | CTNNAL1 OGT CTC1 HUWE1 CUBN FAM171B THOC2 ERBIN MADD RESF1 AOPEP ADAMTS18 CEP295 CPLANE1 CCDC171 KIF11 PCNT | 1.68e-06 | 1084 | 139 | 17 | 11544199 | |
| Pubmed | Compartmentalization of the SUMO/RNF4 pathway by SLX4 drives DNA repair. | 1.89e-06 | 357 | 139 | 10 | 37059091 | |
| Pubmed | CDK8 PDS5B OGT RFC5 THOC2 PALB2 DDX3X MED15 CCNT1 ACTR1A ORC5 CCNT2 PARP1 ARNT RESF1 DYNC1H1 KIF11 | 2.13e-06 | 1103 | 139 | 17 | 34189442 | |
| Pubmed | PDS5B KIF23 UBR4 HUWE1 THOC2 XRN1 HERC2 ASCC3 GCN1 DYNC1H1 PCNT SYMPK XPO7 | 2.40e-06 | 653 | 139 | 13 | 22586326 | |
| Pubmed | 3.45e-06 | 8 | 139 | 3 | 23749998 | ||
| Pubmed | Deletion of Prl7d1 causes placental defects at mid-pregnancy in mice. | 3.45e-06 | 8 | 139 | 3 | 31012985 | |
| Pubmed | 3.69e-06 | 225 | 139 | 8 | 12168954 | ||
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | CEP55 CCNT1 ACTR1A CCNT2 AKAP9 CSK CLK1 CLK2 CLK3 RIN2 BTK CHEK2 CPLANE1 TAF1L PLK4 | 3.95e-06 | 910 | 139 | 15 | 36736316 |
| Pubmed | The protein interaction landscape of the human CMGC kinase group. | CDK8 PDGFRA CDK19 HUWE1 MED15 CCNT1 CCNT2 AKAP9 CLK1 CLK2 CLK3 CHEK2 HERC2 | 4.71e-06 | 695 | 139 | 13 | 23602568 |
| Pubmed | TFIID component TAF7 functionally interacts with both TFIIH and P-TEFb. | 5.16e-06 | 9 | 139 | 3 | 18391197 | |
| Pubmed | 6.02e-06 | 407 | 139 | 10 | 12693553 | ||
| Pubmed | OGT WRN RFC5 ANKZF1 ERBIN CEP55 MED15 CCNT1 ACTR1A ORC5 GZF1 CLK3 XRN1 CBX1 HERC2 ASCC3 TAF1L DNASE1L1 SMG6 | 8.57e-06 | 1497 | 139 | 19 | 31527615 | |
| Pubmed | UBR4 HUWE1 THOC2 DDX3X ACTR1A PARP1 IPO9 ASCC3 GCN1 DYNC1H1 KIF11 SYMPK | 1.05e-05 | 638 | 139 | 12 | 33239621 | |
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | PDS5B RFC5 THOC2 MED15 CCNT1 CCNT2 POLR3B CBX1 TAF1 HERC2 DYNC1H1 | 1.06e-05 | 533 | 139 | 11 | 30554943 |
| Pubmed | 1.15e-05 | 263 | 139 | 8 | 34702444 | ||
| Pubmed | A Large-scale genetic association study of esophageal adenocarcinoma risk. | 1.27e-05 | 351 | 139 | 9 | 20453000 | |
| Pubmed | Insights into the ubiquitin-proteasome system of human embryonic stem cells. | 1.36e-05 | 269 | 139 | 8 | 29511261 | |
| Pubmed | 1.40e-05 | 76 | 139 | 5 | 27542412 | ||
| Pubmed | 1.41e-05 | 449 | 139 | 10 | 31732153 | ||
| Pubmed | PDS5B KIF23 OGT KDM5C UBR4 RFC5 THOC2 MED15 CCNT1 CCNT2 PARP1 POLR3B TAF1 SYMPK XPO7 | 1.42e-05 | 1014 | 139 | 15 | 32416067 | |
| Pubmed | FAT4 KIF23 WRN APBB1 HUWE1 FAM171B ERBIN DNAH7 DDX3X XRN1 GCN1 DYNC1H1 XPO7 | 1.54e-05 | 777 | 139 | 13 | 35844135 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 14612404 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 35181333 | ||
| Pubmed | Regulatory functions of the Mediator kinases CDK8 and CDK19. | 1.59e-05 | 2 | 139 | 2 | 30585107 | |
| Pubmed | PARP-1 regulates mouse embryonic neural stem cell proliferation by regulating PDGFRα expression. | 1.59e-05 | 2 | 139 | 2 | 32295715 | |
| Pubmed | The Cep57-pericentrin module organizes PCM expansion and centriole engagement. | 1.59e-05 | 2 | 139 | 2 | 30804344 | |
| Pubmed | Mouse H-Y encoding Smcy gene and its X chromosomal homolog Smcx. | 1.59e-05 | 2 | 139 | 2 | 10441747 | |
| Pubmed | Inefficient purifying selection: the mammalian Y chromosome in the rodent genus Mus. | 1.59e-05 | 2 | 139 | 2 | 16416087 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 31044597 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 22030621 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 7696711 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 30613976 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 38804708 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 32081420 | ||
| Pubmed | Coding variants in the PCNT and CEP295 genes contribute to breast cancer risk in Chinese women. | 1.59e-05 | 2 | 139 | 2 | 34418690 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 38061684 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 32560467 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 22842574 | ||
| Pubmed | The role of c-Src in platelet-derived growth factor alpha receptor internalization. | 1.59e-05 | 2 | 139 | 2 | 14644164 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 27571988 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 34403156 | ||
| Pubmed | Clinical utility of testing for PALB2 and CHEK2 c.1100delC in breast and ovarian cancer. | 1.59e-05 | 2 | 139 | 2 | 34113003 | |
| Pubmed | [Mechanisms of transcriptional regulation upon protein phosphorylation by mediator complexes]. | 1.59e-05 | 2 | 139 | 2 | 20408451 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 7524912 | ||
| Pubmed | Mediator kinase inhibition further activates super-enhancer-associated genes in AML. | 1.59e-05 | 2 | 139 | 2 | 26416749 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 35393539 | ||
| Pubmed | CDK8/19 Mediator kinases potentiate induction of transcription by NFκB. | 1.59e-05 | 2 | 139 | 2 | 28855340 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 23178280 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 15642393 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 14596914 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 27678455 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 36006697 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 24043304 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 37378433 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 31206626 | ||
| Pubmed | Differential effect of CLK SR Kinases on HIV-1 gene expression: potential novel targets for therapy. | 1.59e-05 | 2 | 139 | 2 | 21682887 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 10070062 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 16195394 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 16519534 | ||
| Pubmed | Analysis of mutation rates in the SMCY/SMCX genes shows that mammalian evolution is male driven. | 1.59e-05 | 2 | 139 | 2 | 9060413 | |
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 12707040 | ||
| Pubmed | 1.59e-05 | 2 | 139 | 2 | 9637771 | ||
| Pubmed | Identification of target genes for the CDK subunits of the Mediator complex. | 1.59e-05 | 2 | 139 | 2 | 22117896 | |
| Pubmed | 1.64e-05 | 457 | 139 | 10 | 22190034 | ||
| Pubmed | 1.74e-05 | 13 | 139 | 3 | 14660691 | ||
| Pubmed | 1.74e-05 | 13 | 139 | 3 | 7805729 | ||
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | PDS5B OGT UBR4 WRN HUWE1 RFC5 THOC2 DDX3X CCNT1 PARP1 IPO9 CLK2 BTK CBX1 ASCC3 GCN1 DYNC1H1 | 2.17e-05 | 1318 | 139 | 17 | 30463901 |
| Pubmed | The ubiquitin ligase TRIM25 targets ERG for degradation in prostate cancer. | 2.20e-05 | 14 | 139 | 3 | 27626314 | |
| Pubmed | NBEAL1 UBR4 PEPD LENG9 MADD ACTR1B ACTR1A IPO9 AKAP9 CLK3 TAF1L SYMPK | 2.24e-05 | 689 | 139 | 12 | 36543142 | |
| Interaction | MED4 interactions | CDK8 CDK19 HUWE1 THOC2 ERBIN CEP55 MED15 SPC24 ACTR1A POLR3B XRN1 HERC2 KIF11 PCNT | 2.43e-06 | 450 | 137 | 14 | int:MED4 |
| Interaction | YWHAH interactions | PDE3B KIF23 OGT PSD3 APBB1 HUWE1 WDR37 ERBIN DNAH7 DDX3X MADD IPO9 RESF1 AKAP9 CSK CLK2 CLK3 XRN1 CRYBG3 PLK4 KIF11 PCNT | 5.12e-06 | 1102 | 137 | 22 | int:YWHAH |
| Interaction | THRAP3 interactions | CDK8 KIF23 OGT ABHD12B MATN2 APBB1 MADD PARP1 CLK1 CLK2 CLK3 CBX1 SMG6 | 1.06e-05 | 443 | 137 | 13 | int:THRAP3 |
| Interaction | MRC1 interactions | 1.68e-05 | 8 | 137 | 3 | int:MRC1 | |
| Interaction | CLK1 interactions | 1.93e-05 | 219 | 137 | 9 | int:CLK1 | |
| Interaction | MLLT1 interactions | 2.12e-05 | 123 | 137 | 7 | int:MLLT1 | |
| Interaction | ITGB3 interactions | 2.16e-05 | 170 | 137 | 8 | int:ITGB3 | |
| Interaction | NIN interactions | KIF23 RFC5 CEP55 SPC24 ACTR1A XRN1 CEP295 HERC2 CPLANE1 DYNC1H1 PCNT | 3.52e-05 | 359 | 137 | 11 | int:NIN |
| Interaction | BIVM-ERCC5 interactions | 3.56e-05 | 10 | 137 | 3 | int:BIVM-ERCC5 | |
| Interaction | HERC2 interactions | CDK8 UBR4 WRN APBB1 DDX3X ARNT AKAP9 CLK2 TAF1 HERC2 TAF1L ATP4A KIF11 | 4.00e-05 | 503 | 137 | 13 | int:HERC2 |
| Interaction | LYPD3 interactions | 5.10e-05 | 141 | 137 | 7 | int:LYPD3 | |
| Interaction | SAMD9L interactions | 6.46e-05 | 12 | 137 | 3 | int:SAMD9L | |
| Interaction | KDM1A interactions | OGT UBR4 HUWE1 THOC2 PALB2 RESF1 AKAP9 XRN1 CBX1 TAF1 CRYBG3 ASCC3 CEP57 GCN1 KIF11 TANGO6 PCNT SYMPK | 7.02e-05 | 941 | 137 | 18 | int:KDM1A |
| Interaction | TP53BP1 interactions | CDK8 OGT CTC1 CDK19 HUWE1 THOC2 PALB2 MED15 CCNT1 PARP1 CHEK2 HERC2 PCNT | 7.21e-05 | 533 | 137 | 13 | int:TP53BP1 |
| Interaction | MED1 interactions | 8.43e-05 | 206 | 137 | 8 | int:MED1 | |
| Interaction | MED26 interactions | 9.10e-05 | 107 | 137 | 6 | int:MED26 | |
| Interaction | S100A2 interactions | KIF23 MATN2 PALB2 SPC24 RESF1 CEP295 CRYBG3 CEP57 DHX34 PCNT SYMPK | 1.21e-04 | 412 | 137 | 11 | int:S100A2 |
| Interaction | PHF21A interactions | 1.21e-04 | 343 | 137 | 10 | int:PHF21A | |
| Interaction | PP2D1 interactions | 1.37e-04 | 3 | 137 | 2 | int:PP2D1 | |
| Interaction | AKAP9 interactions | 1.37e-04 | 221 | 137 | 8 | int:AKAP9 | |
| Interaction | IMPDH2 interactions | KIF23 OGT UBR4 HUWE1 DDX3X PARP1 AKAP9 CLK1 CRYBG3 ASCC3 DYNC1H1 | 1.43e-04 | 420 | 137 | 11 | int:IMPDH2 |
| Interaction | RCOR1 interactions | OGT UBR4 HUWE1 PALB2 ACTR1A RESF1 XRN1 CBX1 TAF1 ASCC3 GCN1 TANGO6 | 1.43e-04 | 494 | 137 | 12 | int:RCOR1 |
| Interaction | SLX4 interactions | PDS5B KIF23 OGT WRN PEPD DDX3X CCNT1 PARP1 RESF1 ASCC3 GCN1 DYNC1H1 SYMPK | 1.46e-04 | 572 | 137 | 13 | int:SLX4 |
| Interaction | CCND1 interactions | 1.51e-04 | 286 | 137 | 9 | int:CCND1 | |
| GeneFamily | CDC like kinases | 4.75e-07 | 4 | 90 | 3 | 480 | |
| GeneFamily | Cyclins|P-TEFb complex | 1.46e-04 | 4 | 90 | 2 | 1281 | |
| GeneFamily | Cyclins|Mediator complex | 5.84e-04 | 33 | 90 | 3 | 1061 | |
| GeneFamily | ATP binding cassette subfamily A | 2.14e-03 | 14 | 90 | 2 | 805 | |
| GeneFamily | AT-rich interaction domain containing | 2.47e-03 | 15 | 90 | 2 | 418 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | CDK8 PDS5B KIF23 OGT CDK19 WRN PSD3 SPG11 THOC2 WDR37 ORC5 AKAP9 RIN2 CRYBG3 ASCC3 KIF11 PCNT | 2.78e-06 | 856 | 138 | 17 | M4500 |
| Coexpression | GSE8835_CD4_VS_CD8_TCELL_UP | 1.14e-05 | 200 | 138 | 8 | M6254 | |
| Coexpression | HALLMARK_G2M_CHECKPOINT | 1.14e-05 | 200 | 138 | 8 | M5901 | |
| Coexpression | GSE23505_IL6_IL1_VS_IL6_IL1_IL23_TREATED_CD4_TCELL_UP | 1.14e-05 | 200 | 138 | 8 | M7869 | |
| Coexpression | AFFAR_YY1_TARGETS_DN | 7.36e-05 | 260 | 138 | 8 | M1471 | |
| Coexpression | FUJII_YBX1_TARGETS_DN | 7.81e-05 | 194 | 138 | 7 | M14340 | |
| Coexpression | GSE23321_CD8_STEM_CELL_MEMORY_VS_NAIVE_CD8_TCELL_DN | 8.33e-05 | 196 | 138 | 7 | M8441 | |
| Coexpression | GSE25088_CTRL_VS_IL4_AND_ROSIGLITAZONE_STIM_STAT6_KO_MACROPHAGE_UP | 8.60e-05 | 197 | 138 | 7 | M8022 | |
| Coexpression | GSE30083_SP3_VS_SP4_THYMOCYTE_UP | 9.45e-05 | 200 | 138 | 7 | M5036 | |
| Coexpression | GSE22140_HEALTHY_VS_ARTHRITIC_GERMFREE_MOUSE_CD4_TCELL_UP | 9.45e-05 | 200 | 138 | 7 | M7648 | |
| Coexpression | GSE29164_UNTREATED_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY3_DN | 9.45e-05 | 200 | 138 | 7 | M8485 | |
| Coexpression | GSE21774_CD62L_POS_CD56_BRIGHT_VS_CD62L_NEG_CD56_DIM_NK_CELL_DN | 9.45e-05 | 200 | 138 | 7 | M7495 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.09e-10 | 195 | 139 | 10 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | PDE3B NBEAL1 ADGRV1 HUWE1 THOC2 AKAP9 CRYBG3 CPLANE1 DYNC1H1 | 1.03e-08 | 193 | 139 | 9 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-08 | 195 | 139 | 9 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.27e-07 | 200 | 139 | 8 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26-Stem_cells-Neuroepithelial_cell|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 2.27e-07 | 200 | 139 | 8 | 203b9a5de4430713da01b3331e69381db449a3a0 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26-Stem_cells|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 2.27e-07 | 200 | 139 | 8 | a854e19703dc920e48304541e2b06ed013292f3e | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.26e-07 | 160 | 139 | 7 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.26e-07 | 160 | 139 | 7 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | C_02|World / shred on cell type and cluster | 8.92e-07 | 165 | 139 | 7 | a456c2c9ffe8dc91e17cac84ba87b88e016f8e6d | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.01e-06 | 168 | 139 | 7 | d35944fd9fea9934ce1e76b2b35d48e2300cca61 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.05e-06 | 169 | 139 | 7 | b253a4a50c06d36228fcd5d856c57202cbac158f | |
| ToppCell | 10x5'-Lung-Lymphocytic_T_CD4/8-lo-Cycling_T|Lung / Manually curated celltypes from each tissue | 1.13e-06 | 171 | 139 | 7 | 976361f67dd725870e0513ae7a92f2dcaee17148 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.27e-06 | 174 | 139 | 7 | dbb4e1a6c3319ce40f81bfd2d1745a88a2cc412e | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.27e-06 | 174 | 139 | 7 | 7b2f35add804981c7d588a996bdbca6ec11a1ca5 | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.27e-06 | 174 | 139 | 7 | 6c36d607c48267a75ab4da6fb2fe3f931d1b3b52 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling-Cycling_Distal_Convoluted_Tubule_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.32e-06 | 175 | 139 | 7 | 876cea684faf42ff3eb4623ad6d7a1fb1276ee02 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.43e-06 | 177 | 139 | 7 | 4197cf2b1e743230c821f422836fa5991b155a52 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.48e-06 | 178 | 139 | 7 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.85e-06 | 184 | 139 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.85e-06 | 184 | 139 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.85e-06 | 184 | 139 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-classical_monocyte_proliferating-classical_monocyte_proliferating_l33-52|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.92e-06 | 185 | 139 | 7 | 47c69500877b851c0c9744f5e1ef2ee0bff99168 | |
| ToppCell | COVID-19-kidney-Mito-rich_PCT|kidney / Disease (COVID-19 only), tissue and cell type | 2.06e-06 | 187 | 139 | 7 | 738ec2611b4be6a08eedad16b57fba84e1f11fef | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.06e-06 | 187 | 139 | 7 | 057569c9437219ecc396aa6e673b1178a2273837 | |
| ToppCell | Multiple_Sclerosis-Lymphocyte-T_NK-T_NK_proliferative|Multiple_Sclerosis / Disease, Lineage and Cell Type | 2.13e-06 | 188 | 139 | 7 | 6c05797a5d0635d89ffcf4aca52178687129ccb4 | |
| ToppCell | pdx-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 2.29e-06 | 190 | 139 | 7 | d06ee5f89f1cec8db6897fe3b2a890a07cd3697b | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating2_(11)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.37e-06 | 191 | 139 | 7 | 0ba5b112a82e489f5a21966f78a403a7436ce73b | |
| ToppCell | P03-Mesenchymal-developing_mesenchymal_cell-mesenchymal_proliferating_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.37e-06 | 191 | 139 | 7 | b978afe76754cc56e1672abca27be289bb56375b | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating2_(11)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.45e-06 | 192 | 139 | 7 | 0a54c79dcfdeb99e3b512d42b22359618cfd17e9 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating2_(11)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.45e-06 | 192 | 139 | 7 | 026f3e38970bea1e6e8d76a4e2becdfb8484b2ff | |
| ToppCell | Proliferating|World / shred by cell class for mouse tongue | 2.45e-06 | 192 | 139 | 7 | f081f3f957cc782294e118fcc1055f6a4264ee98 | |
| ToppCell | control-Myeloid-Immature_Neutrophils_2|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.54e-06 | 193 | 139 | 7 | 33349830e9eba506470ad3661fad5e5a283d20ca | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.62e-06 | 194 | 139 | 7 | f39a471293ecc5c5967b00e772b8f48ebc9affbe | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.62e-06 | 194 | 139 | 7 | f9070035553bc68106a9e0bdf4b507715a138aba | |
| ToppCell | 3'_v3-blood-Lymphocytic_NK-Cycling_NK|blood / Manually curated celltypes from each tissue | 2.62e-06 | 194 | 139 | 7 | bf9734abaad603ade2a6a6940918aaf1e1c4e2cd | |
| ToppCell | Control-Lymphoid_T/NK-T/NK_proliferative|Control / Disease group, lineage and cell class | 2.62e-06 | 194 | 139 | 7 | 9bbb124001fba7450f4639f47f9b720a483e7242 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.62e-06 | 194 | 139 | 7 | a75ecd0b0a928d4646602f7d16a645f6b3df3af5 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.62e-06 | 194 | 139 | 7 | 17744fd6645cf5a447a01a83f07e8d305c2bcd9c | |
| ToppCell | control-Lymphocytic-Prol._cells|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.62e-06 | 194 | 139 | 7 | 4c76508de3291c952386caffda2d559629ba5998 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.62e-06 | 194 | 139 | 7 | e14f66f7584909621b776292fbd52808273fd2ee | |
| ToppCell | Healthy/Control-T/NK_proliferative|Healthy/Control / Disease group and Cell class | 2.72e-06 | 195 | 139 | 7 | 957458fdc39723f4a31bd7fd3ce32891aa3fd462 | |
| ToppCell | control-Myeloid-Immature_Neutrophils_2|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.72e-06 | 195 | 139 | 7 | bfaceb0601cf3855f38d6e1f482f01ad03ef11fe | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-T_cell-T_cells_proliferating-T_cells_proliferating_L.1.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.81e-06 | 196 | 139 | 7 | 9d4f0a95e49bda25864cbe27e4e86096cba5609f | |
| ToppCell | Control-T/NK_proliferative|Control / Disease condition and Cell class | 2.81e-06 | 196 | 139 | 7 | 7b7bc25aef49bfd64f79303a92d527bf8188f7a6 | |
| ToppCell | severe_COVID-19-T/NK_proliferative|World / disease group, cell group and cell class (v2) | 2.90e-06 | 197 | 139 | 7 | 189d97a6c2ff8803db8cc05e205c9d88dac3911f | |
| ToppCell | Mild_COVID-19-T/NK-proliferating_T/NK|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 2.90e-06 | 197 | 139 | 7 | 5fd52fba2cb6fa67377f873da2ff6ce9c83b0591 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.90e-06 | 197 | 139 | 7 | 84ed777cdba569200a3ef1654d8a12f17fcfb7f1 | |
| ToppCell | Healthy/Control-T/NK_proliferative|World / Disease group and Cell class | 2.90e-06 | 197 | 139 | 7 | 4a4d3083938783d6f5b87da02f10e501917da0b4 | |
| ToppCell | COVID-19_Severe-T/NK_proliferative|COVID-19_Severe / Disease condition and Cell class | 2.90e-06 | 197 | 139 | 7 | 718a84e9a8248080f2d964e7c6a3ba183ece9592 | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.90e-06 | 197 | 139 | 7 | d7a9296092153cf66426911fecd810f0c1ef978e | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.90e-06 | 197 | 139 | 7 | dcff23240bb7cb652d7426b29355aa74442ef6fc | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.90e-06 | 197 | 139 | 7 | 434a5686a103bb766e0d80038413f0e12ea3981a | |
| ToppCell | Mild-Lymphoid-T-Proliferating_T|Mild / Condition, Lineage, Cell class and cell subclass | 2.90e-06 | 197 | 139 | 7 | 794517c70089da109f4c6489fe406c0ba6882b76 | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.90e-06 | 197 | 139 | 7 | 6bddfa199ca812d9e518eaa02c3d4fb67e9f5b16 | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.90e-06 | 197 | 139 | 7 | c0a71a9452febda433bc544e4ac0a79c43dcf13e | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.90e-06 | 197 | 139 | 7 | f34b1e34f1f0694564031077172c890b233ce8b7 | |
| ToppCell | droplet-Thymus-nan-3m-Lymphocytic-DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.90e-06 | 197 | 139 | 7 | 9b2c67de46bd59bf56c81a0d10b84cf4a041c120 | |
| ToppCell | mild-Myeloid-Immature_Neutrophils_2|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.90e-06 | 197 | 139 | 7 | bd9d57e0c873f6526dca322f4dad8e6bd692586c | |
| ToppCell | Healthy_donor-T/NK_proliferative|Healthy_donor / disease group, cell group and cell class (v2) | 2.90e-06 | 197 | 139 | 7 | b6bbf87e5823fa66b4cad6a7be4f777356887b59 | |
| ToppCell | COVID-19_Moderate-T/NK_proliferative|COVID-19_Moderate / disease group, cell group and cell class | 3.00e-06 | 198 | 139 | 7 | 166c000fb0e19602ffdd8bf2b2f19be2c6df96a6 | |
| ToppCell | COVID-19_Moderate-T/NK_proliferative|World / disease group, cell group and cell class | 3.00e-06 | 198 | 139 | 7 | bf0131fbca6032e1aab4aa807f8c1d3be689cb7f | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.10e-06 | 199 | 139 | 7 | 11c3d9fe811a4619347f47d2b0e94066e3085625 | |
| ToppCell | mild_COVID-19-T/NK_proliferative|World / disease group, cell group and cell class (v2) | 3.10e-06 | 199 | 139 | 7 | d44cc74d7171d96add61dae821daf774b17d4c69 | |
| ToppCell | VE-cycling|VE / Condition, Cell_class and T cell subcluster | 3.10e-06 | 199 | 139 | 7 | 47c47ebc318a0b98841ca2656837bbd068899559 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.10e-06 | 199 | 139 | 7 | 36c80907b2ec1cbcd1b4e841e6c02a4792591d74 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.10e-06 | 199 | 139 | 7 | bf4c31902ae8358215245a2e11b5a2fe4ca1bc8c | |
| ToppCell | COVID-19_Mild-Lymphoid_T/NK-T/NK_proliferative|COVID-19_Mild / Disease group, lineage and cell class | 3.10e-06 | 199 | 139 | 7 | ddea0e5c1cb6a096ab8e09a8c3c37c1bff381d9c | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.10e-06 | 199 | 139 | 7 | 7beb0e07a27fea94674f24eb61c381b0de38ed3e | |
| ToppCell | COVID-19_Mild-T/NK_proliferative|COVID-19_Mild / Disease condition and Cell class | 3.10e-06 | 199 | 139 | 7 | 9f9a88d2b099646c1e1a7ee3f8d39cb1a2498ad7 | |
| ToppCell | VE-cycling-|VE / Condition, Cell_class and T cell subcluster | 3.10e-06 | 199 | 139 | 7 | c0a67149a19b65b3069dbc5261d81f658e6e39a2 | |
| ToppCell | mild_COVID-19-T/NK_proliferative|mild_COVID-19 / disease group, cell group and cell class (v2) | 3.10e-06 | 199 | 139 | 7 | df2fcaf01b1b48632f84e7355ef21d20853f0664 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-T/NK_proliferative|COVID-19_Mild / Disease, condition lineage and cell class | 3.21e-06 | 200 | 139 | 7 | 6126a3bbafe2110fba0c1c4493035df4e8193d22 | |
| ToppCell | mLN-T_cell-cycling_gd_T|mLN / Region, Cell class and subclass | 3.21e-06 | 200 | 139 | 7 | 4efeef51f885ee8f6dd3911a536cc49e3c14da98 | |
| ToppCell | healthy_donor-Lymphocytic-Proliferative_Lymphocyte|healthy_donor / Disease condition, Lineage, Cell class and subclass | 3.21e-06 | 200 | 139 | 7 | e4eb915c29909cf8535a3603c68976545c05e54b | |
| ToppCell | mLN-(1)_T_cell-(18)_cycling_gd_T|mLN / shred on region, Cell_type, and subtype | 3.21e-06 | 200 | 139 | 7 | e8a0a88a8344e80783931115bbe6cd5b62a4c1f7 | |
| ToppCell | healthy_donor-Lymphocytic-Proliferative_Lymphocyte-|healthy_donor / Disease condition, Lineage, Cell class and subclass | 3.21e-06 | 200 | 139 | 7 | 415e7556b5ac45688e2c6c30a52bd40e0eb27c7d | |
| ToppCell | MS-Multiple_Sclerosis-Lymphocyte-T/NK-T/NK_proliferative|Multiple_Sclerosis / Disease, condition lineage and cell class | 3.21e-06 | 200 | 139 | 7 | 7faf1e37364203a08d2b2544979e848b41e36b1c | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Proliferating|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 3.21e-06 | 200 | 139 | 7 | cea58274efbe7f9e3c3ef9fbb768ebfb917e21d9 | |
| ToppCell | 356C-Lymphocytic-NK_cells-Proliferating_NK_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.21e-06 | 200 | 139 | 7 | 5d11a2c0021805e78d97dc1638bf73ca1faede66 | |
| ToppCell | MS-IIF-Lymphocyte-T/NK-T/NK_proliferative|IIF / Disease, condition lineage and cell class | 3.21e-06 | 200 | 139 | 7 | c7c1806a1054b2b034a26a18aac93fc3bec4dbc8 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-Dividing_AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.21e-06 | 200 | 139 | 7 | af3dc76b4507bf4edd265169f5dfbbb8a19eb394 | |
| ToppCell | Neuronal-Excitatory-eE(FEZF2_SLC17A7)-eE_2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.21e-06 | 200 | 139 | 7 | d31e26387d879ee30731c497cea6aaf4746e40d9 | |
| ToppCell | mild-T/NK_proliferative|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.21e-06 | 200 | 139 | 7 | 63cc57b9331459efbb73051d174d198a3568b938 | |
| ToppCell | PND07-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.63e-06 | 146 | 139 | 6 | 45d7cb73776e60d22f335a651845e21e16948fcc | |
| ToppCell | TCGA-Kidney-Primary_Tumor-Renal_Cell_Carcinoma-Kidney_Clear_Cell_Renal_Carcinoma-6|TCGA-Kidney / Sample_Type by Project: Shred V9 | 9.69e-06 | 156 | 139 | 6 | d249747c7108a0edfc72d24c09b0b0e4ed662b40 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.33e-05 | 165 | 139 | 6 | eec2d327c94832d1390314c93ef6a2be4648478b | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.43e-05 | 167 | 139 | 6 | 50c29ea660bf07b890e4ac1a1985d0761d863dee | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.58e-05 | 170 | 139 | 6 | 6b91d4cbe0697b65bfb2e099e7a9b39ea2fba3a9 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.63e-05 | 171 | 139 | 6 | f5014e3c387fe3118944af392abe10d6b9b0abab | |
| ToppCell | droplet-Lung-1m-Hematologic-Lymphocytic_NK_ILC-natural_killer_cell-proliferating_NK|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.74e-05 | 173 | 139 | 6 | c399786aa25bdbe3394988db6955842b5b7e6b41 | |
| ToppCell | droplet-Lung-LUNG-1m-Lymphocytic-Proliferating_NK|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-05 | 173 | 139 | 6 | 31784679190fbd95fc23d7c66008eb21b8c7cc5d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.80e-05 | 174 | 139 | 6 | 84da9faff088d05233183b425385beb054c92d1b | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_TBCC|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.80e-05 | 174 | 139 | 6 | 912a9e892b29d945666fc37c986009c97c668ac8 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.80e-05 | 174 | 139 | 6 | f90ca117b729436cf452e2ddcec26ba525c5c13b | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.80e-05 | 174 | 139 | 6 | 7d4b860e05b5931f6f9d757a68f75ff35597a47a | |
| ToppCell | facs-Skin-Anagen-24m-Epithelial-actively_dividing_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.98e-05 | 177 | 139 | 6 | 8a0f0fbb06cdacb99a3fdba0da3e0494b891db4f | |
| ToppCell | facs-Skin-Anagen-24m-Epithelial-keratinocyte_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.98e-05 | 177 | 139 | 6 | e9d7682517fb30fd2ad535d59779d718a7024c13 | |
| ToppCell | 10x5'-blood-Lymphocytic_NK-Cycling_NK|blood / Manually curated celltypes from each tissue | 2.11e-05 | 179 | 139 | 6 | c93711273055a999335ba8d0f6500e4549f46cec | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.11e-05 | 179 | 139 | 6 | d1ef7e1cb00336118e387b47f4f8120f53584391 | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Mac-Cycling_Myeloid-Mac|lymph-node_spleen / Manually curated celltypes from each tissue | 2.18e-05 | 180 | 139 | 6 | 4eea8366cdb82c356325ce88f09ad8b302c17a07 | |
| Drug | tandutinib | 1.67e-06 | 15 | 138 | 4 | CID003038522 | |
| Drug | Carcinine [56897-53-1]; Up 200; 22uM; MCF7; HT_HG-U133A | 3.32e-06 | 197 | 138 | 9 | 3242_UP | |
| Disease | developmental and epileptic encephalopathy 87 (implicated_via_orthology) | 2.02e-05 | 2 | 133 | 2 | DOID:0112221 (implicated_via_orthology) | |
| Disease | Neoplasm of uncertain or unknown behavior of breast | 3.51e-05 | 41 | 133 | 4 | C0496956 | |
| Disease | Breast adenocarcinoma | 3.51e-05 | 41 | 133 | 4 | C0858252 | |
| Disease | Colorectal Carcinoma | ABCA13 WRN CUBN PARP1 ARNT AKAP9 ABCA6 LRRC3B GUCY2C CHEK2 PCDH11X ADAMTS18 | 8.35e-05 | 702 | 133 | 12 | C0009402 |
| Disease | telomere length | 9.12e-05 | 313 | 133 | 8 | EFO_0004505 | |
| Disease | syndromic X-linked intellectual disability (is_implicated_in) | 1.20e-04 | 4 | 133 | 2 | DOID:0060309 (is_implicated_in) | |
| Disease | syndromic X-linked intellectual disability Claes-Jensen type (implicated_via_orthology) | 1.20e-04 | 4 | 133 | 2 | DOID:0060809 (implicated_via_orthology) | |
| Disease | heel bone mineral density, urate measurement | 1.82e-04 | 182 | 133 | 6 | EFO_0004531, EFO_0009270 | |
| Disease | Arterial Fatty Streak | 2.00e-04 | 5 | 133 | 2 | C0015697 | |
| Disease | Atheroma | 2.00e-04 | 5 | 133 | 2 | C0264956 | |
| Disease | Plaque, Atherosclerotic | 2.00e-04 | 5 | 133 | 2 | C2936350 | |
| Disease | Fibroatheroma | 2.00e-04 | 5 | 133 | 2 | C2936351 | |
| Disease | Intellectual Disability | 2.02e-04 | 447 | 133 | 9 | C3714756 | |
| Disease | breast carcinoma | PDS5B PALB2 MADD CEP55 KCNU1 AKAP9 CLK1 AOPEP LPA RIN2 CHEK2 LRRD1 PCNT SMG6 | 2.12e-04 | 1019 | 133 | 14 | EFO_0000305 |
| Disease | angina pectoris | 2.62e-04 | 125 | 133 | 5 | EFO_0003913 | |
| Disease | Colorectal Neoplasms | 2.71e-04 | 277 | 133 | 7 | C0009404 | |
| Disease | triglycerides:total lipids ratio, intermediate density lipoprotein measurement | 2.82e-04 | 127 | 133 | 5 | EFO_0008595, EFO_0020947 | |
| Disease | Corneal astigmatism | 4.14e-04 | 77 | 133 | 4 | EFO_1002040 | |
| Disease | Profound Mental Retardation | 4.28e-04 | 139 | 133 | 5 | C0020796 | |
| Disease | Mental Retardation, Psychosocial | 4.28e-04 | 139 | 133 | 5 | C0025363 | |
| Disease | Mental deficiency | 4.28e-04 | 139 | 133 | 5 | C0917816 | |
| Disease | phospholipids:total lipids ratio, high density lipoprotein cholesterol measurement | 5.02e-04 | 307 | 133 | 7 | EFO_0004612, EFO_0020946 | |
| Disease | AUTISM, SUSCEPTIBILITY TO, 15 | 5.55e-04 | 8 | 133 | 2 | C2677504 | |
| Disease | female breast cancer (is_implicated_in) | 5.55e-04 | 8 | 133 | 2 | DOID:0050671 (is_implicated_in) | |
| Disease | triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement | 6.05e-04 | 150 | 133 | 5 | EFO_0004611, EFO_0020947 | |
| Disease | nevus count, cutaneous melanoma | 7.79e-04 | 91 | 133 | 4 | EFO_0000389, EFO_0004632 | |
| Disease | squamous cell carcinoma, esophageal carcinoma | 8.86e-04 | 10 | 133 | 2 | EFO_0000707, EFO_0002916 | |
| Disease | melanoma | 9.35e-04 | 248 | 133 | 6 | C0025202 | |
| Disease | free cholesterol to total lipids in very small VLDL percentage | 9.68e-04 | 43 | 133 | 3 | EFO_0022290 | |
| Disease | grey matter volume measurement | 1.04e-03 | 44 | 133 | 3 | EFO_0005420 | |
| Disease | C-reactive protein measurement | PSD3 SPG11 CCDC168 THOC2 MADD IPO9 ABCA6 AOPEP LPA SPHKAP CCDC171 GCN1 G6PC1 NR1H4 | 1.12e-03 | 1206 | 133 | 14 | EFO_0004458 |
| Disease | Malignant neoplasm of breast | ABHD12B UBR4 CUBN PALB2 DDX3X PARP1 AKAP9 LRRC3B BTK CHEK2 SLC39A6 HERC2 G6PC1 | 1.16e-03 | 1074 | 133 | 13 | C0006142 |
| Disease | type 2 diabetes mellitus (implicated_via_orthology) | 1.33e-03 | 105 | 133 | 4 | DOID:9352 (implicated_via_orthology) | |
| Disease | serum albumin measurement | 1.49e-03 | 592 | 133 | 9 | EFO_0004535 | |
| Disease | Ciliopathies | 1.57e-03 | 110 | 133 | 4 | C4277690 | |
| Disease | coronary artery disease, factor VII measurement | 1.63e-03 | 111 | 133 | 4 | EFO_0001645, EFO_0004619 | |
| Disease | apolipoprotein A 1 measurement | PDE3B PEPD PSD3 SPG11 MADD SPC24 ABCA6 LPA LPIN2 TANGO6 SMG6 | 1.63e-03 | 848 | 133 | 11 | EFO_0004614 |
| Disease | lipoprotein A measurement | 1.68e-03 | 112 | 133 | 4 | EFO_0006925 | |
| Disease | glucose measurement | 1.73e-03 | 380 | 133 | 7 | EFO_0004468 | |
| Disease | trimethylamine-N-oxide measurement | 1.77e-03 | 14 | 133 | 2 | EFO_0010541 | |
| Disease | urinary bladder cancer (biomarker_via_orthology) | 1.77e-03 | 14 | 133 | 2 | DOID:11054 (biomarker_via_orthology) | |
| Disease | Hereditary Breast and Ovarian Cancer Syndrome | 1.77e-03 | 14 | 133 | 2 | C0677776 | |
| Disease | Metastatic melanoma | 1.88e-03 | 54 | 133 | 3 | C0278883 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 1.94e-03 | 195 | 133 | 5 | DOID:1574 (implicated_via_orthology) | |
| Disease | omega-6 polyunsaturated fatty acid measurement | 2.03e-03 | 197 | 133 | 5 | EFO_0005680 | |
| Disease | von Willebrand factor measurement, coronary artery disease | 2.04e-03 | 118 | 133 | 4 | EFO_0001645, EFO_0004629 | |
| Disease | Meckel-Gruber syndrome | 2.04e-03 | 15 | 133 | 2 | C0265215 | |
| Disease | Proteinuria | 2.04e-03 | 15 | 133 | 2 | HP_0000093 | |
| Disease | response to platinum based chemotherapy, magnesium measurement | 2.04e-03 | 15 | 133 | 2 | EFO_0004647, EFO_0004845 | |
| Disease | syndromic intellectual disability (implicated_via_orthology) | 2.32e-03 | 16 | 133 | 2 | DOID:0050888 (implicated_via_orthology) | |
| Disease | Atherosclerosis | 2.42e-03 | 59 | 133 | 3 | C0004153 | |
| Disease | colon cancer (is_marker_for) | 2.42e-03 | 59 | 133 | 3 | DOID:219 (is_marker_for) | |
| Disease | triglycerides to total lipids in small LDL percentage | 2.42e-03 | 59 | 133 | 3 | EFO_0022337 | |
| Disease | Atherogenesis | 2.42e-03 | 59 | 133 | 3 | C1563937 | |
| Disease | cholesteryl esters to total lipids in large HDL percentage | 2.42e-03 | 59 | 133 | 3 | EFO_0022248 | |
| Disease | lobe attachment | 2.52e-03 | 207 | 133 | 5 | EFO_0007667 | |
| Disease | bone mineral content measurement | 2.89e-03 | 130 | 133 | 4 | EFO_0007621 | |
| Disease | coronary artery disease, plasminogen activator inhibitor 1 measurement | 2.92e-03 | 63 | 133 | 3 | EFO_0001645, EFO_0004792 | |
| Disease | coronary artery disease | CDK8 PDS5B FAT4 NBEAL1 PSD3 VWDE SPC24 PARP1 LPA CHRDL1 MMP13 DNASE1L1 SMG6 | 2.94e-03 | 1194 | 133 | 13 | EFO_0001645 |
| Disease | Global developmental delay | 3.14e-03 | 133 | 133 | 4 | C0557874 | |
| Disease | Hereditary Non-Polyposis Colon Cancer Type 2 | 3.28e-03 | 19 | 133 | 2 | C1333991 | |
| Disease | Colorectal cancer, hereditary nonpolyposis, type 1 | 3.28e-03 | 19 | 133 | 2 | C2936783 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | 3.40e-03 | 222 | 133 | 5 | EFO_0008317, EFO_0020943 | |
| Disease | squamous cell carcinoma | 3.47e-03 | 67 | 133 | 3 | EFO_0000707 | |
| Disease | glycine measurement | 3.49e-03 | 137 | 133 | 4 | EFO_0009767 | |
| Disease | triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement | 3.60e-03 | 225 | 133 | 5 | EFO_0008317, EFO_0020947 | |
| Disease | Familial aplasia of the vermis | 3.63e-03 | 20 | 133 | 2 | cv:C0431399 | |
| Disease | Adenocarcinoma of prostate | 3.63e-03 | 20 | 133 | 2 | C0007112 | |
| Disease | triglycerides to total lipids in very small VLDL percentage | 3.78e-03 | 69 | 133 | 3 | EFO_0022341 | |
| Disease | triglyceride measurement, body fat percentage | 4.00e-03 | 21 | 133 | 2 | EFO_0004530, EFO_0007800 | |
| Disease | Joubert syndrome 1 | 4.00e-03 | 21 | 133 | 2 | C4551568 | |
| Disease | tissue plasminogen activator measurement, coronary artery disease | 4.09e-03 | 71 | 133 | 3 | EFO_0001645, EFO_0004791 | |
| Disease | severe acute respiratory syndrome, COVID-19 | 4.24e-03 | 447 | 133 | 7 | EFO_0000694, MONDO_0100096 | |
| Disease | Seckel syndrome | 4.39e-03 | 22 | 133 | 2 | C0265202 | |
| Disease | seminoma (is_marker_for) | 4.39e-03 | 22 | 133 | 2 | DOID:4440 (is_marker_for) | |
| Disease | Hepatitis | 4.39e-03 | 22 | 133 | 2 | HP_0012115 | |
| Disease | Down syndrome (is_marker_for) | 4.39e-03 | 22 | 133 | 2 | DOID:14250 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PSFLTDQELKHLILE | 156 | P27540 | |
| ALKTQTPQLHFLDTD | 466 | Q86US8 | |
| NITVLFLHSNKLETL | 346 | Q96RT1 | |
| NLPKEETEFLSIHSQ | 1296 | Q99996 | |
| LTHEFLQILEKTPNR | 236 | O60583 | |
| EELFHPLTSLQTLKL | 186 | P22792 | |
| LLTKNRFSSHPLENE | 221 | Q5JVX7 | |
| PNVIALQKVFLSHSD | 76 | Q9BWU1 | |
| SFVSVQDLKTHQRLP | 66 | Q2NKJ3 | |
| LKFELNRSHISETPL | 611 | Q68DQ2 | |
| LAEKHLFSTIPELIN | 346 | Q06187 | |
| LTHTDLKPENILFVN | 286 | P49760 | |
| NDFTLQLPKLHLETF | 1171 | Q6TFL3 | |
| VLLESKSSPFNLLHE | 6 | Q9H116 | |
| HFEVQSSKVPNLSLI | 406 | Q6V0I7 | |
| TLVHTEILKLFPQAA | 1521 | Q8N139 | |
| NIPFLVILISTTHKE | 76 | Q9Y5Z6 | |
| DENVKFLSSPLLILH | 286 | Q7Z5M8 | |
| KDQLQTFSEEHPVLL | 96 | P42025 | |
| NTTLFVHLLDDNIPE | 2766 | Q8WXG9 | |
| SLKQLHEFAITEPLV | 396 | Q53EZ4 | |
| FDHQQLAKLIQESPT | 376 | Q86XR8 | |
| QLTHTDLKPENILFV | 426 | P49761 | |
| FSLSHDLQNSPKIII | 1606 | Q86UQ4 | |
| PSFLQLREQLEHIKT | 431 | P41240 | |
| LSLDHSKLVDVPFQV | 516 | O00213 | |
| AEFNITLIHPKDLTA | 231 | P15144 | |
| EHLLEQKTLSPRTLQ | 716 | Q8N6M6 | |
| ELTHEFLQILEKTPN | 236 | O60563 | |
| PFSEHRTQVSLKDQI | 426 | O96017 | |
| LTFEEHINNIKPSII | 801 | O60879 | |
| QELHLELKPSAILSS | 106 | Q8TE60 | |
| ELKPSAILSSHFIVQ | 111 | Q8TE60 | |
| HTDLKPENILFVQSD | 286 | P49759 | |
| KIDTSTLNLFQHLPE | 2296 | Q6ZS30 | |
| ETQFAQIFEPLHKSL | 741 | Q9NTI5 | |
| ISKFEVNNTILHPEI | 166 | P12955 | |
| IFPLETNETNHVSLK | 476 | P25092 | |
| HSQLQKQFASLTLPE | 1246 | O75747 | |
| TKSLQELFLAHILSP | 466 | P09874 | |
| TLHISPKQFVVDLLA | 856 | Q17RG1 | |
| KTELTPDQQTLLHFI | 256 | Q96RI1 | |
| EIKPTFSQLEAVNLH | 316 | P16234 | |
| DISNVKHVINFDLPS | 506 | O00571 | |
| EIPVDISFSKQLLHL | 501 | A4D1F6 | |
| ELQEIASEPTNKHLF | 801 | O00339 | |
| SLNTQPILNLEKFHE | 436 | Q8WXG6 | |
| STPTLLESIQHVFIK | 4026 | O95714 | |
| IPRTLHQIFEKLTDN | 136 | P52732 | |
| DLLLEITAFHSQTLP | 86 | A9Z1Z3 | |
| LFDSQPDLLHQLVTL | 546 | Q9BY66 | |
| GSQVHLPKLEFTLSQ | 456 | Q96B70 | |
| LHPQQVDAELFLTKS | 311 | P45452 | |
| SPQLAKLQESFITHI | 981 | Q13370 | |
| LKNTPQVSLHRFETI | 341 | Q6ZU69 | |
| LQLPDKHSVTALLNT | 761 | Q96RN5 | |
| SIHIKVDPLFTELLN | 2376 | Q92616 | |
| ILTELKNPSNIHFIE | 861 | A8MYU2 | |
| ITSIPNEIFKDLHQL | 76 | Q96PB8 | |
| HSPKNLLLNFVTIEE | 876 | Q9BZA7 | |
| VLDTLIQLAKVFPSH | 3336 | Q7Z6Z7 | |
| QPFHQEEKESLSLQL | 1081 | O95613 | |
| SLDALVTFHQQKPIE | 101 | Q96JZ2 | |
| DQHPSATLFVKISLQ | 741 | P51178 | |
| HDLKNIRFTSPVSLE | 276 | Q86YC2 | |
| NLSKTPALQLVHELF | 436 | Q4G163 | |
| KHLEISFDNNFLIPS | 2841 | O60494 | |
| ELKLSQAHSVQPLSL | 271 | P49184 | |
| PLKTSQDLIHQLEVF | 616 | Q9UBT7 | |
| IKTEQSFRLIPLQHS | 971 | Q9H799 | |
| ELPHFKLVTRTTLSQ | 401 | Q9BU40 | |
| PTFQELQRVLHKLTT | 331 | Q9H8Y5 | |
| VHIDTTPFASLLKNL | 251 | P35575 | |
| SIIDVNLPKFLSHDL | 1531 | Q8WXX0 | |
| PDLIAEFLQSQKTAH | 61 | P83916 | |
| KDQLQTFSEEHPVLL | 96 | P61163 | |
| LLFLKSAAPEQSHVV | 11 | P08519 | |
| LQVFPSHSALKLEDI | 301 | Q96JA4 | |
| APENLTLHKLSESQL | 156 | P31785 | |
| DQLKVSESTHVLQPF | 546 | Q96P70 | |
| DIKHLLPVETQRFQS | 1556 | Q14204 | |
| IFEAEQLSLPHTLNI | 4521 | Q8NDH2 | |
| VFTLNHPLTIASVDK | 121 | Q8IXS0 | |
| PNVISLQKVFLSHAD | 76 | P49336 | |
| SKIFSSHLQIPQLQD | 1321 | Q9C0D2 | |
| HQLLSFVSLLETNKP | 876 | Q14147 | |
| FHTVDTILLQEKPNS | 16 | Q9ULB4 | |
| TNKFQLSIHTLEDPR | 496 | P20648 | |
| QLLFLHQDILTSPVS | 46 | Q68DL7 | |
| ILQTSDLFSTPEQLH | 541 | Q6P995 | |
| HFSTLAIKQNPLLAE | 76 | O15294 | |
| SHSVFNIKLVQAPLD | 301 | Q02241 | |
| SKHVLLPVFNSVELV | 131 | Q5VVY1 | |
| DDLLLPAQSTLQTKH | 906 | Q2M3C7 | |
| AIITFHPQKLSQEEL | 241 | Q96GJ1 | |
| FNTLLPHANETKEIL | 1816 | O60522 | |
| LSTIQKFINEDRLPH | 41 | P40937 | |
| FIPHTSLQVKNSQLL | 236 | Q9HCM1 | |
| NLIDPIHEFKALTNT | 191 | Q8IVG5 | |
| QHDATKLLPSVTELF | 236 | Q8IZX4 | |
| QHDATKLLPSVTELF | 216 | P21675 | |
| VTQTLLKTLELPHVF | 46 | O43913 | |
| QNIHSLFPVLIDTKS | 281 | Q8NA58 | |
| FLVAQSIHKEPSLEL | 831 | Q7Z3Z4 | |
| THDKLLVNQTELFVP | 106 | Q6RSH7 | |
| ILQDLQPFLVKTSSH | 746 | Q14191 | |
| PSFLSIEAKDLIHQL | 231 | O00444 | |
| LTFALSVTNPLHELK | 11 | Q13433 | |
| VLTPQFLSHDKDQLT | 516 | Q08AH1 | |
| LKDSSLLTLPNIENH | 1956 | Q8N3C0 | |
| PQSKHFSEQLLNLTL | 601 | Q96JI7 | |
| KDLNHVSLSSLIPEL | 651 | Q8N2E2 | |
| FINPLFLKVHSQDLS | 271 | Q8WYP3 | |
| TEHYSPLSLLKQELQ | 46 | Q8NBP0 | |
| TLVVAHLPFDDTNLK | 231 | Q6SA08 | |
| ELVHQQKTPNFSTLL | 1001 | Q8NI27 | |
| VLFLISLTQKIPTAH | 2101 | Q8N2C7 | |
| IDSFLTQHPQEIIFL | 146 | Q0VAA5 | |
| QPIHLDSTQLSRKFI | 171 | Q8NBT2 | |
| APFLSDIHNISTLKI | 486 | Q8IZH2 | |
| EPFSSKSLLELEQHQ | 616 | Q9C0B7 | |
| EVSLSHKDNIIFSPL | 36 | O75830 | |
| NKDTTHLEIEPFTLL | 651 | Q9NW08 | |
| LHNKPTFSQTIVLLN | 36 | Q8WU68 | |
| KPFQVDVILDLNTAH | 291 | Q495X7 | |
| LSVLKHPASLEFQAQ | 306 | Q92797 | |
| FLQLSLPTQDEKTHI | 126 | Q6ZN19 | |
| SVNSIKFHPSEQLAL | 201 | Q9Y2I8 | |
| FSTKDILSQHERLLP | 221 | Q9H707 | |
| QTFIKLLLSIPHSDL | 866 | Q9UIA9 | |
| VLTHSLFLPTEKFLQ | 181 | Q9UHV5 | |
| NVPQEALDKLLSFTH | 626 | A3KMH1 | |
| QLHEIPSLQSIYTLD | 1111 | Q5T4S7 | |
| SHLKEQSLQPIDSLI | 121 | Q9NYI0 | |
| HKADLLPISASVQFI | 606 | Q96GX1 | |
| QLSLPTQLEKTHIRE | 201 | Q6ZNA1 | |
| EPNLTKSQSNIHVLF | 501 | A8MPX8 | |
| LFDSQPDLLHQLVTL | 556 | P41229 | |
| LVEHVFPLLSKEQNS | 856 | Q92539 | |
| ELTDQIFTLALQHPA | 1691 | Q6PIF6 | |
| ELHLIFNNKEIFSSP | 1036 | Q5VTT5 |